Gossamer Bio
Stock Forecast, Prediction & Price Target
Gossamer Bio Financial Estimates
Gossamer Bio Revenue Estimates
Gossamer Bio EBITDA Estimates
Gossamer Bio Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $3.65M Low: $3.65M High: $3.65M avg. 0% | Avg: $48.29M Low: $48.29M High: $48.29M avg. 1223.25% | Avg: $108.57M Low: $108.57M High: $108.57M avg. 124.80% | Avg: $205.55M Low: $205.55M High: $205.55M avg. 89.31% |
Net Income
% change YoY
| $-249.07M N/A | $-240.22M 3.55% | $-179.81M 25.14% | Avg: $-188.03M Low: $-146.51M High: $-85.46M avg. -4.57% | Avg: $-118.72M Low: $-135.83M High: $19.84M avg. 36.86% | Avg: $-28.74M Low: $-28.74M High: $-28.74M avg. 75.78% | Avg: $10.68M Low: $10.68M High: $10.68M avg. 137.16% |
EBITDA
% change YoY
| $-214.48M N/A | $-215.43M -0.44% | $-172.15M 20.09% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$3.33 N/A | -$2.84 14.71% | -$1.18 58.45% | Avg: -$0.76 Low: -$0.96 High: -$0.56 avg. 35.72% | Avg: -$0.45 Low: -$0.89 High: $0.13 avg. 41.10% | Avg: -$0.19 Low: -$0.19 High: -$0.19 avg. 57.83% | Avg: $0.07 Low: $0.07 High: $0.07 avg. 137.16% |
Operating Expenses
% change YoY
| $216.04M N/A | $218.52M 1.14% | $183.75M -15.91% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Gossamer Bio stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 61.31% in 2025-2028.
We have gathered data from 8 analysts. Their low estimate is -146.51M, average is -188.03M and high is -85.46M.
What is Gossamer Bio stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 359.34% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is $3.65M, average is $3.65M and high is $3.65M.
What is Gossamer Bio stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 67.95% in 2025-2028.
We have gathered data from 8 analysts. Their low earnings per share estimate is -$0.96, average is -$0.76 and high is $-0.56.
What is the best performing analyst?
In the last twelve months analysts have been covering Gossamer Bio stock. The most successful analyst is David Hoang.